FindTrial
Sign In

The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage

The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011593
Enrollment
Unknown
Registered
2017-06-07
Start date
2014-01-13
Completion date
Unknown
Last updated
2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Threatened miscarriage

Interventions

Micronised progesterone:Micronised progesterone
Duphaston:Duphaston

Sponsors

KK Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
21 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included single intrauterine pregnancy at 6-10 weeks of gestational age (as measured by crown-rump length of fetal pole, with or without positive cardiac activity) and per vaginal bleeding.

Exclusion criteria

Exclusion criteria: Exclusion criteria included inevitable miscarriage, prior use of progestogen in current pregnancy, history of recurrent miscarriages (defined as 3 or more consecutive miscarriages), and pregnancies conceived using assisted reproductive technology.

Design outcomes

Primary

MeasureTime frame
Serum progesterone;Serum PIBF;—

Secondary

MeasureTime frame
Miscarriage;Extent of per vaginal bleeding at follow up;—

Countries

Singapore

Contacts

Public ContactTan Thiam Chye

Singapore

tan.thiam.chye@kkh.com.sg+65 81211679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026